Cart
sales@molnova.com
ZEN-3862
CAS No. 1952264-33-3
ZEN-3862( ZEN 3862 | ZEN3862 )
Catalog No. M26520 CAS No. 1952264-33-3
ZEN-3862 is an inhibitor of BET(IC50s of 0.16 and 0.13 μM for BRD4(BD1) and BRD4(BD2) , respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 125 | Get Quote |
|
| 5MG | 205 | Get Quote |
|
| 10MG | 320 | Get Quote |
|
| 25MG | 565 | Get Quote |
|
| 50MG | 799 | Get Quote |
|
| 100MG | 1071 | Get Quote |
|
| 500MG | 2151 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZEN-3862
-
NoteResearch use only, not for human use.
-
Brief DescriptionZEN-3862 is an inhibitor of BET(IC50s of 0.16 and 0.13 μM for BRD4(BD1) and BRD4(BD2) , respectively).
-
DescriptionZEN-3862 is an inhibitor of BET(IC50s of 0.16 and 0.13 μM for BRD4(BD1) and BRD4(BD2) , respectively). ZEN-3862 can be used to form PROTACs to induce degradation of BRD4.
-
In Vitro——
-
In Vivo——
-
SynonymsZEN 3862 | ZEN3862
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1952264-33-3
-
Formula Weight340.354
-
Molecular FormulaC19H17FN2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (244.84 mM)
-
SMILESCc1noc(C)c1-c1ccc(=O)n(Cc2ccc(C3CO3)c(F)c2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sikorska H, et al. [Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency]. Pol Merkur Lekarski. 2010 Jun;28(168):490-5.
molnova catalog
related products
-
Rilematovir
JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.
-
Coryneine
Coryneine is a quaternary ammonium derivative of dopamine derived from aconite root.
-
Lomibuvir
Lomibuvir (VCH-222) is a selective, non-nucleoside allosteric inhibitor of HCV NS5B polymerase (RdRp) with a Kd of 17 nM. Lomibuvir inhibits the 1b/Con1 HCV subgenomic replicon with an EC 50 of 5.2 nM.
